Abattis Bioceuticals Corp.
ATTBF
$0.00
$0.000.00%
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.22% | -46.34% | -76.81% | -40.19% | 1,573.41% |
| Total Receivables | -69.89% | -82.99% | -92.21% | 44.30% | 328.27% |
| Inventory | 757.20% | 568.32% | 59.44% | -- | -- |
| Prepaid Expenses | -3.64% | -0.51% | -28.98% | -53.23% | 2,809.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.38% | -40.20% | -74.19% | -39.24% | 1,389.38% |
|
|
|||||
| Total Current Assets | -66.38% | -40.20% | -74.19% | -39.24% | 1,389.38% |
| Net Property, Plant & Equipment | 1.94% | -47.60% | 49.42% | 81.99% | 32.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -90.22% | -90.51% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 64.99% | -70.71% | -82.53% | 7.01% | 810.26% |
|
|
|||||
| Total Accounts Payable | -3.93% | -20.19% | -26.19% | -9.95% | -6.29% |
| Total Accrued Expenses | -48.70% | -51.36% | -67.17% | -45.61% | -63.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 25,518.88% | -- | -- | -- |
| Total Other Current Liabilities | -- | 25,518.88% | -- | -- | -- |
| Total Current Liabilities | 1,482.43% | 276.22% | -92.02% | -31.26% | -33.29% |
|
|
|||||
| Total Current Liabilities | 1,482.43% | 276.22% | -92.02% | -31.26% | -33.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2,668.36% | 545.08% | -92.02% | -31.26% | -33.29% |
|
|
|||||
| Common Stock & APIC | 2.68% | 3.81% | 4.08% | 191.46% | 376.13% |
| Retained Earnings | 0.49% | -120.51% | -146.69% | -237.39% | -324.27% |
| Treasury Stock & Other | -166.61% | -139.45% | -156.58% | -108.14% | 9.12% |
| Total Common Equity | -5.84% | -82.54% | -81.54% | 8.23% | 628.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.84% | -82.54% | -81.54% | 8.23% | 628.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.38% | -0.57% | 3.46% | 8.11% | 49.78% |
| Total Equity | -6.13% | -83.01% | -81.99% | 8.82% | 1,290.81% |
|
|
|||||
